Women using Ozempic for weight loss have reported a surprising side effect known as ‘Ozempic vulva.’ Designed as a treatment for type 2 diabetes, this GLP-1 receptor agonist is not advised for off-label use.
Despite its primary purpose, many have embraced Ozempic for its rapid weight loss results. However, this has led to unforeseen changes in the body, including the phenomenon called ‘Ozempic vulva.’

‘Ozempic vulva’ describes changes to the vulva experienced by some women on the drug. Though not officially acknowledged by manufacturers, these changes have sparked conversations among users.
Sherry Ross, M.D., an OB-GYN in Santa Monica, has noted that some women observe alterations in their vulva due to the rapid weight loss induced by Ozempic.
A Reddit user shared their struggle, describing pain during exercise caused by a loss of vulvar fat pads. Their gynecologist diagnosed a ‘saggy vulva,’ recommending surgery or fillers as remedies.

Dr. Michael Tahrey confirms that rapid weight loss from Ozempic can cause visible sagging of the labia or vagina due to a reduction in overall fat and volume.
This sagging stems from loose skin, wrinkles, or disproportionate labia in the vaginal area, a frequent consequence of significant weight loss.
While no formal studies have surveyed vaginal changes in GLP-1 users, Dr. Ross lists potential effects like altered discharge, odor, and decreased lubrication.

Other changes may include more frequent vaginal infections, reduced vulvar fullness, weakened pelvic floor strength, and disruptions to the menstrual cycle.
Dr. Ross explains that the skin cannot keep up with rapid weight loss, resulting in sagging and laxity in areas like the lower belly, pubic mons, and labia.
Dr. Melanie Bone, a consultant OBGYN, told Newsweek that the impact of GLP-1 agonists like Ozempic on vaginal health is often ignored.
She highlights that rapid weight loss can disrupt hormone levels, potentially leading to vaginal dryness and affecting tissue health unexpectedly.
Gastrointestinal side effects from Ozempic, such as nausea and diarrhea, may cause dehydration, which can exacerbate vaginal dryness and discomfort.
Diet and gut microbiome changes from these medications might also indirectly influence the vaginal microbiome through the gut-vagina connection.
To address ‘Ozempic vulva,’ treatments range from cosmetic procedures like labiaplasty to pelvic floor exercises or regaining weight to restore vulvar fullness.

Dr. Bone warns that labiaplasty carries risks, including infection, scarring, and potential dissatisfaction, urging patients to weigh their options carefully.
Novo Nordisk, Ozempic’s manufacturer, prioritizes patient safety and advises using the drug only under medical supervision, encouraging UK patients to report side effects via the MHRA Yellow Card scheme.
